Robust expression of the human neonatal Fc receptor in a truncated soluble form and as a full-length membrane-bound protein in fusion with eGFP.

Studies on the neonatal Fc receptor (FcRn) have revealed a multitude of important functions in mammals, including protection of IgG and serum albumin (SA) from lysosomal degradation. The pharmacokinetic behavior of therapeutic antibodies, IgG-Fc- and SA-containing drugs is therefore influenced by th...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Johan Seijsing, Malin Lindborg, John Löfblom, Mathias Uhlén, Torbjörn Gräslund
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2013
Materias:
R
Q
Acceso en línea:https://doaj.org/article/e4060617ee8a4ebb811b810ebd70a15b
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:e4060617ee8a4ebb811b810ebd70a15b
record_format dspace
spelling oai:doaj.org-article:e4060617ee8a4ebb811b810ebd70a15b2021-11-18T08:46:07ZRobust expression of the human neonatal Fc receptor in a truncated soluble form and as a full-length membrane-bound protein in fusion with eGFP.1932-620310.1371/journal.pone.0081350https://doaj.org/article/e4060617ee8a4ebb811b810ebd70a15b2013-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24260574/?tool=EBIhttps://doaj.org/toc/1932-6203Studies on the neonatal Fc receptor (FcRn) have revealed a multitude of important functions in mammals, including protection of IgG and serum albumin (SA) from lysosomal degradation. The pharmacokinetic behavior of therapeutic antibodies, IgG-Fc- and SA-containing drugs is therefore influenced by their interaction with FcRn. Pre-clinical development of such drugs is facilitated if their interaction with FcRn can be studied in vitro. For this reason we have developed a robust system for production of the soluble extracellular domain of human FcRn as well as the full-length receptor as fusion to green fluorescent protein, taking advantage of a lentivirus-based gene delivery system where stable over-expressing cells are easily and rapidly generated. Production of the extracellular domain in multiple-layered culture flasks, followed by affinity purification using immobilized IgG, resulted in capture of milligram amounts of soluble receptor per liter cell culture with retained IgG binding. The receptor was further characterized by SDS-PAGE, western blotting, circular dichroism spectroscopy, ELISA, surface plasmon resonance and a temperature stability assay showing a functional and stable protein of high purity. The full-length receptor was found to be successfully over-expressed in a membrane-bound form with retained pH-dependent IgG- and SA-binding.Johan SeijsingMalin LindborgJohn LöfblomMathias UhlénTorbjörn GräslundPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 8, Iss 11, p e81350 (2013)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Johan Seijsing
Malin Lindborg
John Löfblom
Mathias Uhlén
Torbjörn Gräslund
Robust expression of the human neonatal Fc receptor in a truncated soluble form and as a full-length membrane-bound protein in fusion with eGFP.
description Studies on the neonatal Fc receptor (FcRn) have revealed a multitude of important functions in mammals, including protection of IgG and serum albumin (SA) from lysosomal degradation. The pharmacokinetic behavior of therapeutic antibodies, IgG-Fc- and SA-containing drugs is therefore influenced by their interaction with FcRn. Pre-clinical development of such drugs is facilitated if their interaction with FcRn can be studied in vitro. For this reason we have developed a robust system for production of the soluble extracellular domain of human FcRn as well as the full-length receptor as fusion to green fluorescent protein, taking advantage of a lentivirus-based gene delivery system where stable over-expressing cells are easily and rapidly generated. Production of the extracellular domain in multiple-layered culture flasks, followed by affinity purification using immobilized IgG, resulted in capture of milligram amounts of soluble receptor per liter cell culture with retained IgG binding. The receptor was further characterized by SDS-PAGE, western blotting, circular dichroism spectroscopy, ELISA, surface plasmon resonance and a temperature stability assay showing a functional and stable protein of high purity. The full-length receptor was found to be successfully over-expressed in a membrane-bound form with retained pH-dependent IgG- and SA-binding.
format article
author Johan Seijsing
Malin Lindborg
John Löfblom
Mathias Uhlén
Torbjörn Gräslund
author_facet Johan Seijsing
Malin Lindborg
John Löfblom
Mathias Uhlén
Torbjörn Gräslund
author_sort Johan Seijsing
title Robust expression of the human neonatal Fc receptor in a truncated soluble form and as a full-length membrane-bound protein in fusion with eGFP.
title_short Robust expression of the human neonatal Fc receptor in a truncated soluble form and as a full-length membrane-bound protein in fusion with eGFP.
title_full Robust expression of the human neonatal Fc receptor in a truncated soluble form and as a full-length membrane-bound protein in fusion with eGFP.
title_fullStr Robust expression of the human neonatal Fc receptor in a truncated soluble form and as a full-length membrane-bound protein in fusion with eGFP.
title_full_unstemmed Robust expression of the human neonatal Fc receptor in a truncated soluble form and as a full-length membrane-bound protein in fusion with eGFP.
title_sort robust expression of the human neonatal fc receptor in a truncated soluble form and as a full-length membrane-bound protein in fusion with egfp.
publisher Public Library of Science (PLoS)
publishDate 2013
url https://doaj.org/article/e4060617ee8a4ebb811b810ebd70a15b
work_keys_str_mv AT johanseijsing robustexpressionofthehumanneonatalfcreceptorinatruncatedsolubleformandasafulllengthmembraneboundproteininfusionwithegfp
AT malinlindborg robustexpressionofthehumanneonatalfcreceptorinatruncatedsolubleformandasafulllengthmembraneboundproteininfusionwithegfp
AT johnlofblom robustexpressionofthehumanneonatalfcreceptorinatruncatedsolubleformandasafulllengthmembraneboundproteininfusionwithegfp
AT mathiasuhlen robustexpressionofthehumanneonatalfcreceptorinatruncatedsolubleformandasafulllengthmembraneboundproteininfusionwithegfp
AT torbjorngraslund robustexpressionofthehumanneonatalfcreceptorinatruncatedsolubleformandasafulllengthmembraneboundproteininfusionwithegfp
_version_ 1718421356027052032